Doberstein Stephen K

SVP & Chief Scientific Officer at NKTR

Sold, on record
$30.7M
Dollars the filings state
Form 4 sales
17
Latest Aug 16, 2019
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NKTRNEKTAR THERAPEUTICSSVP & Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NKTRUnusual
    Nov 8 2017

    Sold 396,323 shares at $29.00 ($11.5M)

    Doberstein Stephen K, SVP & Chief Scientific Officer

    Sold 92.7% of holdings ($12.4M position)31,102 shares left296.6x usual sizeFiling

  2. 2 Form 4 sale NKTRPlan not stated
    Feb 16 +100 days

    Sold 2,426 shares at $82.94 ($201k)

    Doberstein Stephen K, SVP & Chief Scientific Officer

    Sold 3.5% of holdings ($5.8M position)67,394 shares left1.6x usual sizeFiling

  3. 3 Form 4 sale NKTRUnusual
    Apr 9 +52 days

    Sold 160,000 shares at $93.06 ($14.9M)

    Doberstein Stephen K, SVP & Chief Scientific Officer

    Sold 70.4% of holdings ($21.2M position)67,394 shares left94.1x usual sizeFiling

  4. 4 Form 4 sale NKTRPlan not stated
    May 16 +37 days

    Sold 3,435 shares at $83.39 ($286k)

    Doberstein Stephen K, SVP & Chief Scientific Officer

    Sold 5.1% of holdings ($5.6M position)63,959 shares left2x usual sizeFiling

  5. 5 Form 4 sale NKTRPlan not stated
    Nov 16 +184 days

    Sold 4,524 shares at $38.25 ($173k)

    Doberstein Stephen K, SVP & Chief Scientific Officer

    Sold 5.4% of holdings ($3.2M position)78,734 shares left1.5x usual sizeFiling

  6. 6 Form 4 sale NKTRPlan not stated
    Feb 19 +95 days

    Sold 3,310 shares at $42.39 ($140k)

    Doberstein Stephen K, SVP & Chief Scientific Officer

    Sold 3.2% of holdings ($4.4M position)99,374 shares left0.7x usual sizeFiling

  7. 7 Form 4 sale NKTRPlan not stated
    May 16 +86 days

    Sold 3,461 shares at $31.37 ($109k)

    Doberstein Stephen K, SVP & Chief Scientific Officer

    Sold 3.5% of holdings ($3.1M position)95,913 shares left1x usual sizeFiling

  8. 8 Form 4 sale NKTRPlan not stated
    Aug 16 +92 days

    Sold 3,245 shares at $18.15 ($59k)

    Doberstein Stephen K, SVP & Chief Scientific Officer

    Sold 3.4% of holdings ($1.7M position)92,668 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Doberstein Stephen K
Source
Aug 16, 2019NKTRSVP & Chief Scientific OfficerForm 4 sale3,245$59k3.4%Plan not statedSEC
May 16, 2019NKTRSVP & Chief Scientific OfficerForm 4 sale3,461$109k3.5%Plan not statedSEC
Feb 19, 2019NKTRSVP & Chief Scientific OfficerForm 4 sale3,310$140k3.2%Plan not statedSEC
Nov 16, 2018NKTRSVP & Chief Scientific OfficerForm 4 sale4,524$173k5.4%Plan not statedSEC
May 16, 2018NKTRSVP & Chief Scientific OfficerForm 4 sale3,435$286k5.1%Plan not statedSEC
Apr 9, 2018NKTRSVP & Chief Scientific OfficerForm 4 sale160,000$14.9M70.4%UnusualSEC
Feb 16, 2018NKTRSVP & Chief Scientific OfficerForm 4 sale2,426$201k3.5%Plan not statedSEC
Nov 8, 2017NKTRSVP & Chief Scientific OfficerForm 4 sale396,323$11.5M92.7%UnusualSEC
Oct 5, 2017NKTRSVP & Chief Scientific OfficerForm 4 sale43,677$1.1M58.4%UnusualSEC
Aug 16, 2017NKTRSVP & Chief Scientific OfficerForm 4 sale1,701$33k5.2%Plan not statedSEC
May 16, 2017NKTRSVP & Chief Scientific OfficerForm 4 sale1,701$33k4.9%Plan not statedSEC
Apr 5, 2017NKTRSVP & Chief Scientific OfficerForm 4 sale100,000$2.2M74.3%UnusualSEC
Feb 16, 2017NKTRSVP & Chief Scientific OfficerForm 4 sale1,261$17k3.5%Plan not statedSEC
Nov 16, 2016NKTRSVP & Chief Scientific OfficerForm 4 sale670$9k3.5%Plan not statedSEC
Aug 16, 2016NKTRSVP & Chief Scientific OfficerForm 4 sale1,336$23k6.6%Plan not statedSEC
May 17, 2016NKTRSVP & Chief Scientific OfficerForm 4 sale339$5k24.9%Plan not statedSEC
Feb 17, 2016NKTRSVP & Chief Scientific OfficerForm 4 sale390$5k44.6%UnusualSEC